KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Abbott Laboratories (ABT) Divestments (2017 - 2021)

Abbott Laboratories' Divestments history spans 5 years, with the latest figure at $86.0 million for Q3 2021.

On a quarterly basis, Divestments changed N/A to $86.0 million in Q3 2021 year-over-year; TTM through Dec 2022 was $86.0 million, a 10.42% decrease, with the full-year FY2024 number at $1.0 million, down 97.5% from a year prior.
Divestments hit $86.0 million in Q3 2021 for Abbott Laboratories, up from $10.0 million in the prior quarter.
Over the last five years, Divestments for ABT hit a ceiling of $1.7 billion in Q1 2017 and a floor of -$29.0 million in Q3 2017.
Historically, Divestments has averaged $391.8 million across 3 years, with a median of $48.0 million in 2020.
The widest YoY moves for Divestments: up 6640.0% in 2017, down 6640.0% in 2017.
Tracing ABT's Divestments over 3 years: stood at $600.0 million in 2017, then plummeted by 98.33% to $10.0 million in 2020, then soared by 760.0% to $86.0 million in 2021.
Business Quant data shows Divestments for ABT at $86.0 million in Q3 2021, $10.0 million in Q4 2020, and $600.0 million in Q4 2017.